Joel Greenblatt Roivant Sciences Ltd. Transaction History
Gotham Asset Management, LLC
- $9.41 Billion
- Q3 2024
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 39,027 shares of ROIV stock, worth $446,078. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,027
Previous 39,537
1.29%
Holding current value
$446,078
Previous $417,000
7.91%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
310Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$754 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$752 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$618 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$476 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$404 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.05B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...